ACUITY HORIZONS bleeding criteria: Difference between revisions

	Bleeding Microchapters
Home
Patient Information
Overview
Classification
Bleeding Academic Research Consortium
TIMI bleeding criteria
GUSTO bleeding criteria
CURE bleeding criteria
ACUITY HORIZONS bleeding criteria
STEEPLE bleeding criteria
PLATO bleeding criteria
GRACE bleeding criteria
Causes
Treatment
Emergency Bleeding Control
Reversal of Anticoagulation and Antiplatelet in Active Bleed
Perioperative Bleeding
Anemia Management
Coagulation Monitoring
Coagulation Management
Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy Antiplatelet Agents Heparin Fondaparinux Vitamin K Antagonists New Oral Anticoagulants Comorbidities Involving Hemostatic Derangement
Specific Surgeries Cardiovascular Surgery Gynecological Bleeding Obstetric Bleeding Orthopedic/Neurosurgery Visceral/Transplant Surgery Pediatric Surgery
Congenital Bleeding Disorders von Willebrand Disease Platelet Defects Hemophilia A and B Factor VII Deficiency Rare Bleeding Disorders
ACUITY HORIZONS bleeding criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of ACUITY HORIZONS bleeding criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on ACUITY HORIZONS bleeding criteria
CDC on ACUITY HORIZONS bleeding criteria
ACUITY HORIZONS bleeding criteria in the news
Blogs on ACUITY HORIZONS bleeding criteria
Directions to Hospitals Treating Bleeding
Risk calculators and risk factors for ACUITY HORIZONS bleeding criteria

VisualWikitext

Latest revision as of 20:15, 29 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Acuity Horizons Bleeding Criteria (DO NOT EDIT)

ACUITY, HORIZONS

“

Major

Intracranial or intraocular hemorrhage
Access-site hemorrhage requiring intervention
≥5-cm hematoma
Retroperitoneal
Reduction in hemoglobin concentration of ≥4 g/dL without an overt source of bleeding
Reduction in hemoglobin concentration of ≥3 g/dL with an overt source of bleeding
Reoperation for bleeding
Use of any blood product transfusion

”

^[1]

References

↑ Amlani S, Nadarajah T, Afzal R, Pal-Sayal R, Eikelboom JW, Natarajan MK (2010). "Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction". J Thromb Thrombolysis. 30 (4): 434–40. doi:10.1007/s11239-010-0462-8. PMID 20213257.

Template:WH Template:WS

[pmid20213257-1] Amlani S, Nadarajah T, Afzal R, Pal-Sayal R, Eikelboom JW, Natarajan MK (2010). "Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction". J Thromb Thrombolysis. 30 (4): 434–40. doi:10.1007/s11239-010-0462-8. PMID 20213257.

[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{SI}}
+{{Bleeding}}
 {{CMG}}
-==Overview==
+==Acuity Horizons Bleeding Criteria (DO NOT EDIT)==
 '''ACUITY, HORIZONS'''
 {{cquote|
+'''Major'''
+* [[intracranial hemorhage|Intracranial]] or [[intraocular hemorrhage]]
+* Access-site hemorrhage requiring intervention
+* ≥5-cm [[hematoma]]
+* [[Retroperitoneal]]
+* Reduction in [[hemoglobin]] concentration of ≥4 g/dL without an overt source of bleeding
+* Reduction in hemoglobin concentration of ≥3 g/dL with an overt source of bleeding
+* Reoperation for [[bleeding]]
+* Use of any blood product transfusion}}<ref name="pmid20213257">{{cite journal| author=Amlani S, Nadarajah T, Afzal R, Pal-Sayal R, Eikelboom JW, Natarajan MK| title=Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction. | journal=J Thromb Thrombolysis | year= 2010 | volume= 30 | issue= 4 | pages= 434-40 | pmid=20213257 | doi=10.1007/s11239-010-0462-8 | pmc= | url= }}</ref>
-*'''Major'''
-Intracranial or intraocular hemorrhage
-Access-site hemorrhage requiring intervention
-≥5-cm hematoma
-Retroperitoneal
-Reduction in hemoglobin concentration of ≥4 g/dL without an overt source of bleeding
-Reduction in hemoglobin concentration of ≥3 g/dL with an overt source of bleeding
-Reoperation for bleeding
-Use of any blood product transfusion}}
-<ref name="pmid20213257">{{cite journal| author=Amlani S, Nadarajah T, Afzal R, Pal-Sayal R, Eikelboom JW, Natarajan MK| title=Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction. | journal=J Thromb Thrombolysis | year= 2010 | volume= 30 | issue= 4 | pages= 434-40 | pmid=20213257 | doi=10.1007/s11239-010-0462-8 | pmc= | url= }} </ref>
 == References ==
 {{Reflist}}
+{{WH}}
-<br>
+{{WS}}
 [[Category:Medical emergencies]]
 [[Category:Blood]]
 [[Category:Hematology]]
-[[bg:Кръвоизлив]]
-[[bs:Krvarenje]]
-[[ca:Hemorràgia]]
-[[cs:Krvácení]]
-[[de:Blutung]]
-[[es:Hemorragia]]
-[[eu:Odoljario]]
-[[fr:Hémorragie]]
-[[it:Emorragia]]
-[[he:דימום]]
-[[la:Haemorrhagia]]
-[[lt:Kraujavimas]]
-[[nl:Versterkte bloedingsneiging]]
-[[ja:出血]]
-[[pl:Krwotok]]
-[[pt:Hemorragia]]
-[[ro:Hemoragie]]
-[[qu:Yawar apariy]]
-[[ru:Кровотечение]]
-[[sv:Blödning]]
-{{WH}}
-{{WS}}

ACUITY HORIZONS bleeding criteria: Difference between revisions

Latest revision as of 20:15, 29 July 2020

Acuity Horizons Bleeding Criteria (DO NOT EDIT)

References

Navigation menu